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have the potential to improve medication safety and reduce health care costs in 
the context of meaningful use.  
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OBJECTIVES: A pragmatic cluster RCT investigated the effectiveness of a 
pharmacist-led information technology-enabled (PINCER) intervention in 
reducing risk of medication errors, in England. General practices were 
randomised to computer-generated simple feedback audit reports on at-risk 
patients (control) or the PINCER intervention comprising feedback, educational 
outreach and dedicated support from a pharmacist (intervention). We compared 
the costs and benefits of the PINCER intervention versus control. METHODS: 
Costs (English NHS perspective), QALYs and net benefit were generated. Error 
rates and intervention costs (corrected for baseline) were combined with 
modelled projected harm and NHS cost, adjusted for proportion of each error. 
Probabilistic Markov models were constructed to quantify the economic impact 
of each medication error (NSAIDs, beta-blockers, ACE-inhibitors, diuretics, 
amiodarone, methotrexate, lithium). A five year time horizon was used. Costs 
and outcomes were discounted at 3.5%. RESULTS: Seventy-two practices (480942 
patients) were randomised to either arm. Mean (SD) error rate reduction per 
practice (simple feedback vs PINCER) at 6 months was 12.90 (0.26) (p<0.001). In 
deterministic analysis, PINCER was dominant, generating 0.81 more QALYs and 
saving £2611 per practice. In probabilistic analysis, PINCER reached 57% 
probability of being cost-effective at £10000 ceiling willingness-to-pay (λ). The 
probability of PINCER being cost-effective had not increased beyond 57% at λ: 
£30000. The mean net benefit generated (λ: £30000) was £21 (SD £91). Practice 
size did not affect results. CONCLUSIONS: This is one of the first studies to 
estimate the economic impact of a safety-focused intervention in health care. In 
the basecase, PINCER is dominant. However, due to uncertainty around the 
clinical and economic consequences of some errors, PINCER could not be 
considered cost-effective under current decision rules. Correcting errors relating 
to certain drugs (NSAIDs and amiodarone) had more impact, such that PINCER 
may be cost-effective if the “right” errors are targeted. Future work will 
investigate including other errors.  
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OBJECTIVES: MTM services aim to optimize care and reduce costs for patients 
taking multiple chronic drugs (poly-pharmacy). This study examined the impact 
of face-to-face MTM services on drug expenditures, medical expenditures and 
total health care costs in. METHODS: MarketScan Commercial Claims and 
Encounters database was used to select: adults >18 years between January 1, 
2007 and December 31, 2010, with face-to-face MTM (CPT codes 99605, 99606, 
99607), and poly-pharmacy (4 or more chronic medications in the 6-months prior 
to index date). The date of the first MTM encounter was the index date. A (100:1) 
age, gender-matched poly-pharmacy control group was formed; the index date 
was that of the matched MTM patient. Nearest-neighbor propensity score 
matching within a caliper (1:1) was run to form two exchangeable study groups 
(n=401) controlling for demographic, drug-related, clinical status-related and 
health services utilization-related covariates. A difference-in-differences (DID) 
model with gamma distribution and log link accounting for three times points 
(period 0: 6 months pre, periods 1 and 2: 6 and 12 months post index date 
respectively) was run for total costs and medical costs. RESULTS: Unadjusted 
DID estimates for period 1 were $3,327 and $6,496 for period 2. DID models 
showed that total health care costs were not significantly different between the 
two groups in period 1 but were 32% less (CI:7%-51%, p-value=0.017) in the MTM 
group in period 2. Period 2 cost reduction was driven by medical costs (34% 
reduction, CI:2%-44%, p-value=0.037); no significant differences in pharmacy 
costs were observed in both periods. CONCLUSIONS: Face-to-face MTM services 
reduced medical costs with no change in pharmacy costs for poly-pharmacy 
patients. Favorable economic outcomes were detected seven months after initial 
MTM exposure. MTM plays a crucial role in reducing overall health care costs for 
chronic poly-pharmacy patients.  
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OBJECTIVES: Patients whose diabetes is managed with polypharmacy are subject 
to increased risk of medication-related problems and non-adherence. The 
objective of this drug therapy management (DTM) program is to integrate 
pharmacy intervention with care management to improve health and reduce 
cost. METHODS: The DTM program is a collaboration between pharmacy benefits 
management (PerformRx) and health plan-based care management (Keystone 
Mercy Health Plan [KMHP] and AmeriHealth Mercy Health Plan [AMHP]) targeting 
members with diabetes who are high utilizers (≥15 medications). Pharmacists 
review member profiles to recommend evidence-based prescriber and/or 
member interventions (e.g., changes in therapy, medication reminders) 
Pharmacists work directly with prescribers to optimize drug therapy, while care 
management provides detailed member coaching to enhance medication 
adherence. The profiles of 954 DTM participants (690 KMHP; 264 AMHP)—with a 
mean seven-fold greater disease burden than the plan average (using DxCG 
prospective risk scoring)—were reviewed for services between November 1, 2010 
to July, 1, 2011, followed by a 3-month claims run-out period, while profiles of 
810 matched control participants (600 KMHP; 210 AMHP) were not reviewed. 
RESULTS: Inpatient (IP) admissions and emergency room (ER) utilization rates 
were lower in the DTM population; however, only the DTM group in KMHP 
demonstrated a statistically significant reduction in IP admissions compared to 
the control group (76.4%; p=0.0002). Additionally, although pharmacy-related 
costs were significantly increased across-the-board, the changes were not 
statistically significant between DTM and control groups; however, total costs 
(medical+pharmacy) were significantly reduced in the DTM group compared to 
the control group (47.8% for KMHP, p=0.0039; 50.7% for AMHP, p=0.0497). The 
overall acceptance rates for diabetes-specific DTM interventions for KMHP and 
AMHP members were 33% and 26%, respectively. CONCLUSIONS: DTM 
Participants demonstrated a significant total cost savings in both health plans, 
and modest-to-significant reductions in ER visits and IP admission compared to 
non-participants.  
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OBJECTIVES: Patient satisfaction is a key outcome measure being examined by 
researchers exploring the relationships between patient outcomes and hospital 
structure and care processes. Only a few non-generalizable studies, however, 
have explored the relationship of nurse staffing and patient satisfaction with 
nursing care in emergency departments of hospitals. METHODS: A mulit-level 
mixed model was developed using more than 182,000 patient satisfaction 
surveys collected over a five-year period from 153 emergency departments (EDs) 
in 107 hospitals in a range of Canadian ED settings including urban and rural, 
community and academic, and small and large health care institutions with 
varying sizes and case mix. Using an established conceptual framework for 
investigating the relationship between nurse staffing and patient outcomes, 
nineteen nurse staffing variables were initially investigated. Ultimately, 
however, only five staffing variables were used in the multi-level regression 
analyzes. These five variables included registered nurse (RN) proportion, RN 
agency proportion, percent full-time nurse worked hours, RN worked hours per 
patient length of stay and registered practical nurse (RPN) worked hours per 
length of stay. Emergency department case mix index, patient age and gender, 
hospital peer group, size, wait times, cleanliness of the emergency department, 
physician courtesy, and year of measurement were controlled to account for 
their effect on the relationship between nursing staffing and patient satisfaction 
in the ED. RESULTS: The study revealed a subset of six patient satisfaction 
variables representing the overall variation in patient satisfaction with nursing 
care in the ED. CONCLUSIONS: Although RN proportion and RPN worked hours 
per length of stay were found to have a statistical association with patient 
satisfaction in the ED, the association was weak and not administratively 
actionable. Interpersonal and environmental factors such as physician and nurse 
courtesy, ED cleanliness and timeliness, however, were areas where hospital 
administrators could improve patient satisfaction in EDs.  
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OBJECTIVES: To assess public use of community pharmacies; evaluate attitudes 
towards the role of community pharmacist; and determine the required 
pharmacists’ characteristics and future services. METHODS: It was a cross-
sectional study using stratified sampling technique among pharmacy-attendees 
in Baghdad from January to March 2012. Data gathered by using a validated self-
administered questionnaire. Mann-Whitney and Kruskal-Wallis tests were 
performed to find the statistical differences among the study variables. Further 
analysis by Chi-square test and logistic regression detected the predictors of 
public’s attitudes. RESULTS: More than two thirds of respondents (70.0%) visited 
the community pharmacies once or more per month. Slightly, more than half of 
respondents (55.4%) rated community pharmacist as the first person to contact 
in case of any drug-related problem. However, poor attitudes towards the 
pharmacist’s role were recognized among the majority of respondents (79.8%). 
Respondent characteristics have led to the significant differences in public 
attitudes. In the multivariate logistic analysis, gender and age were the 
influential predictors for the model. CONCLUSIONS: The use of community 
pharmacy in Iraq was characterized mainly by the frequent visits to purchase 
medicines. The selection of pharmacy depended on its location. Public has 
